Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734136 · ClinicalTrials.gov registry record · NA
Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
A NA study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00734136: Clinical Trial NA study, sponsored by Lahey Clinic.
NCT00734136 is a NA study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734136, a NA study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the factors involved in the repair and regeneration of liver tissue and to see if different types of liver disease are associated with different types of factors, especially in the severe liver disease called hepatorenal syndrome.
Interventions
- PROCEDURE Blood Draws and a hepatectomy specimen
- PROCEDURE Blood draw - pre operative standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-02 |
| Phase | NA |
Why NCT00734136 stopped before completion
NCT00734136 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood Draws and a hepatectomy specimen is the first listed.
NCT00734136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00734136 about?
NCT00734136 is a clinical study titled "Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome". This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the factors involved in the repair and regeneration of liver tissue and to see if different types of live...
What is the current status of trial NCT00734136?
This trial is currently terminated. It is a NA study. The enrollment target is 100 participants. The study started on 2005-05. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00734136?
The interventions under investigation include: Blood Draws and a hepatectomy specimen (PROCEDURE), Blood draw - pre operative standard of care (PROCEDURE).
Who is sponsoring clinical trial NCT00734136?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00734136's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia